Cargando…
The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial
Weight loss (WL) differences between isocaloric high-carbohydrate and high-fat diets are generally small; however, individual WL varies within diet groups. Genotype patterns may modify diet effects, with carbohydrate-responsive genotypes losing more weight on high-carbohydrate diets (and vice versa...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562431/ https://www.ncbi.nlm.nih.gov/pubmed/37813841 http://dx.doi.org/10.1038/s41467-023-41969-1 |
_version_ | 1785118126972600320 |
---|---|
author | Höchsmann, Christoph Yang, Shengping Ordovás, José M. Dorling, James L. Champagne, Catherine M. Apolzan, John W. Greenway, Frank L. Cardel, Michelle I. Foster, Gary D. Martin, Corby K. |
author_facet | Höchsmann, Christoph Yang, Shengping Ordovás, José M. Dorling, James L. Champagne, Catherine M. Apolzan, John W. Greenway, Frank L. Cardel, Michelle I. Foster, Gary D. Martin, Corby K. |
author_sort | Höchsmann, Christoph |
collection | PubMed |
description | Weight loss (WL) differences between isocaloric high-carbohydrate and high-fat diets are generally small; however, individual WL varies within diet groups. Genotype patterns may modify diet effects, with carbohydrate-responsive genotypes losing more weight on high-carbohydrate diets (and vice versa for fat-responsive genotypes). We investigated whether 12-week WL (kg, primary outcome) differs between genotype-concordant and genotype-discordant diets. In this 12-week single-center WL trial, 145 participants with overweight/obesity were identified a priori as fat-responders or carbohydrate-responders based on their combined genotypes at ten genetic variants and randomized to a high-fat (n = 73) or high-carbohydrate diet (n = 72), yielding 4 groups: (1) fat-responders receiving high-fat diet, (2) fat-responders receiving high-carbohydrate diet, (3) carbohydrate-responders receiving high-fat diet, (4) carbohydrate-responders receiving high-carbohydrate diet. Dietitians delivered the WL intervention via 12 weekly diet-specific small group sessions. Outcome assessors were blind to diet assignment and genotype patterns. We included 122 participants (54.4 [SD:13.2] years, BMI 34.9 [SD:5.1] kg/m(2), 84% women) in the analyses. Twelve-week WL did not differ between the genotype-concordant (−5.3 kg [SD:1.0]) and genotype-discordant diets (−4.8 kg [SD:1.1]; adjusted difference: −0.6 kg [95% CI: −2.1,0.9], p = 0.50). With the current ability to genotype participants as fat- or carbohydrate-responders, evidence does not support greater WL on genotype-concordant diets. ClinicalTrials identifier: NCT04145466. |
format | Online Article Text |
id | pubmed-10562431 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-105624312023-10-11 The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial Höchsmann, Christoph Yang, Shengping Ordovás, José M. Dorling, James L. Champagne, Catherine M. Apolzan, John W. Greenway, Frank L. Cardel, Michelle I. Foster, Gary D. Martin, Corby K. Nat Commun Article Weight loss (WL) differences between isocaloric high-carbohydrate and high-fat diets are generally small; however, individual WL varies within diet groups. Genotype patterns may modify diet effects, with carbohydrate-responsive genotypes losing more weight on high-carbohydrate diets (and vice versa for fat-responsive genotypes). We investigated whether 12-week WL (kg, primary outcome) differs between genotype-concordant and genotype-discordant diets. In this 12-week single-center WL trial, 145 participants with overweight/obesity were identified a priori as fat-responders or carbohydrate-responders based on their combined genotypes at ten genetic variants and randomized to a high-fat (n = 73) or high-carbohydrate diet (n = 72), yielding 4 groups: (1) fat-responders receiving high-fat diet, (2) fat-responders receiving high-carbohydrate diet, (3) carbohydrate-responders receiving high-fat diet, (4) carbohydrate-responders receiving high-carbohydrate diet. Dietitians delivered the WL intervention via 12 weekly diet-specific small group sessions. Outcome assessors were blind to diet assignment and genotype patterns. We included 122 participants (54.4 [SD:13.2] years, BMI 34.9 [SD:5.1] kg/m(2), 84% women) in the analyses. Twelve-week WL did not differ between the genotype-concordant (−5.3 kg [SD:1.0]) and genotype-discordant diets (−4.8 kg [SD:1.1]; adjusted difference: −0.6 kg [95% CI: −2.1,0.9], p = 0.50). With the current ability to genotype participants as fat- or carbohydrate-responders, evidence does not support greater WL on genotype-concordant diets. ClinicalTrials identifier: NCT04145466. Nature Publishing Group UK 2023-10-09 /pmc/articles/PMC10562431/ /pubmed/37813841 http://dx.doi.org/10.1038/s41467-023-41969-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Höchsmann, Christoph Yang, Shengping Ordovás, José M. Dorling, James L. Champagne, Catherine M. Apolzan, John W. Greenway, Frank L. Cardel, Michelle I. Foster, Gary D. Martin, Corby K. The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial |
title | The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial |
title_full | The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial |
title_fullStr | The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial |
title_full_unstemmed | The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial |
title_short | The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial |
title_sort | personalized nutrition study (points): evaluation of a genetically informed weight loss approach, a randomized clinical trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562431/ https://www.ncbi.nlm.nih.gov/pubmed/37813841 http://dx.doi.org/10.1038/s41467-023-41969-1 |
work_keys_str_mv | AT hochsmannchristoph thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT yangshengping thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT ordovasjosem thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT dorlingjamesl thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT champagnecatherinem thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT apolzanjohnw thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT greenwayfrankl thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT cardelmichellei thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT fostergaryd thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT martincorbyk thepersonalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT hochsmannchristoph personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT yangshengping personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT ordovasjosem personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT dorlingjamesl personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT champagnecatherinem personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT apolzanjohnw personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT greenwayfrankl personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT cardelmichellei personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT fostergaryd personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial AT martincorbyk personalizednutritionstudypointsevaluationofageneticallyinformedweightlossapproacharandomizedclinicaltrial |